deal with Nestle will lead to POH becoming manufacturer and supplier of high margin phosphorilated Vitamin E to worlds biggest food group. This is potentially enormous.
Backed up by similar arrangement with Johnson and Johnson for Transdermal has the potential to be huge for this company both by way of milestone payments and now royalties on top of margin business.
deal with nestle
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $255 | 107.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 90918113 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 55054085 | 13 |
View Market Depth
| Last trade - 15.44pm 22/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |